The Six-Figure Economics Behind MedTech World’s Four-Continent Expansion

In just six years, MedTech World, the medical-technology conference and exhibition, has grown from a virtual conference launched during the Covid pandemic into a global event ecosystem spanning four annual editions across four continents.

It’s a pace of expansion that’s unusual in an industry that typically spends years establishing a single flagship with a tight-knit community before cautiously spreading its wings to other regions.

This year, MedTech World is putting that model to its biggest test yet, with three-day conferences in Valletta, Malta; Hong Kong; Dubai; and West Palm Beach, Fla.

The company’s expansion strategy has relied on a relatively simple formula: test markets through smaller roadshows before committing to a full event, replicate a largely standardized format and use parent company SiGMA Group’s existing infrastructure to lower some of the cost and complexity of launching in new regions. Now it has to prove that formula can produce four sustainable event businesses.

Test Before You Invest

MedTech World is the brainchild of Dr. Dylan Attard, a surgeon and entrepreneur who during the Covid pandemic launched Tabib.mt, a Maltese telehealth platform connecting patients with medical specialists via video consultations.

Attard later partnered with SiGMA Group, a global events and media company, to launch MedTech World as a virtual conference. The event initially took place alongside SiGMA’s established Medical Cannabiz World event in 2020, with the goal of connecting medical-technology startups with clinicians, investors and government leaders.

The first live edition took place in Malta’s capital city, Valletta, in 2023. Approximately 70% of its 800 attendees traveled from the U.S. that year, quickly revealing an expansion opportunity. By 2025, attendance had climbed to more than 2,000 participants—a 150% increase—with significantly greater representation from Europe and the Middle East.

But rather than immediately replicating the Malta event elsewhere, MedTech World spent its initial growth phase testing potential markets through one-day roadshows in major cities around the world.

The smaller events provided a lower-risk way to determine whether there was sufficient demand for a full-scale conference, while allowing MedTech World to identify potential partners and sponsors and begin building local relationships before making a larger investment.

Those tests ultimately led the company to three markets where it believed there was enough demand to expand: the Middle East, North America and Asia.

Build Once, Replicate Globally

The four-event strategy gives MedTech World a global footprint, but the company isn’t reinventing the wheel every time it enters a new market.

The underlying event format is relatively standardized, save for Malta’s recently expanded itinerary to ensure it remains the clear flagship. Each edition features a live “Startup Pitch” competition where medtech startups showcase their innovations to a panel of judges, as well as investor-only forums and a dedicated exhibition area.

Much of the differentiation instead comes through market-specific cultural programming. In West Palm Beach, for instance, attendees of certain ticket tiers could join a catamaran cruise, while Dubai’s agenda included an off-site visit to the region’s red dunes.

Malta is also adding an invite-only yacht experience aimed primarily at active investors deploying capital into the sector, alongside a small number of senior industry stakeholders. Unlike some of the company’s other experiences, it isn’t an additional paid networking product, but is designed as a curated setting for investors and industry leaders to build relationships.

That allows MedTech World to replicate the core product across markets while tailoring the experience to the region hosting it.

The SiGMA Advantage

MedTech World also hasn’t had to build the infrastructure supporting its expansion entirely from scratch. The company remains part of SiGMA’s tech-focused portfolio, alongside events spanning iGaming, blockchain and affiliate marketing.

SiGMA played a substantial role during MedTech World’s earliest days in terms of staffing, when Attard and Shara Layton, head of marketing, were the company’s only employees. As MedTech World has grown, however, the parent company has taken a more hands-off approach. MedTech World now has 25 full-time employees, with SiGMA mostly responsible for sourcing contractors and providing operational support on-site.

That existing infrastructure has given the relatively young company resources to draw on as it has expanded internationally, rather than recreating every operational function in each new market.

Sponsorship Makes the Model Work

That infrastructure helps, but expanding across four continents still requires substantial capital. MedTech World said launching and delivering an international edition requires a “significant six-figure investment,” although the cost varies depending on the geography, venue, scale and ambition of the event. Upfront expenses include venues, production, operations, technology, marketing and hospitality, as well as the work required to build a local ecosystem.

New events are funded through a combination of reinvestment from the business, resources from the broader MedTech World portfolio and support from sponsors and other partners in the market. That makes sponsorship particularly important to the expansion model.

Sponsorship is by far MedTech World’s primary revenue stream, ranging from investments supporting smaller networking events to enterprise partnerships spanning the company’s global portfolio.

More than 45% of MedTech World’s sponsors now participate in more than one regional event, according to the company. Some remain focused on individual markets because of their commercial priorities, while others use the portfolio to build visibility and relationships internationally.

“Once a sponsor engages with MedTech World, we see an 86% likelihood of them returning,” Layton said.

According to MedTech World’s sponsorship prospectus, turnkey sponsorship packages range from $15,000 for a Supporting Sponsor to $100,000 for a Presenting Sponsor. A la carte opportunities begin at $5,000 for thought leadership placements and reach $55,000 for keynote sponsorships.

Ticket revenue represents a much smaller portion of the business—Layton said Attard has intentionally prioritized affordable access for startups over maximizing ticket revenue, reflecting the company’s mission of democratizing healthcare innovation. U.S. passes are priced at $1,500 or $3,000, with the premium option including cultural tours, a 10-by-10 exhibit booth and tailored investor matchmaking. For comparison, tickets for MedTech World Malta range from €600 (~$690) to €2,000 (~$2,300).

What MedTech World won’t disclose is whether those economics are sufficient to make each individual event profitable. Layton declined to provide overall revenue or profitability figures, or more specific costs associated with individual events.

Now Comes the Hard Part

The first year of MedTech World’s four-event strategy provides some evidence of demand, but not yet proof that the model can produce sustainable events.

MedTech World Middle East was the first on the docket in February, drawing more than 800 attendees, roughly matching the 800 people who attended the inaugural live edition in Malta in 2023. North America followed in May, with more than 600 attendees in West Palm Beach. The Asia edition took place in late August, and attendance figures have not yet been published.

All three markets are still in their first year, making it difficult to determine whether MedTech World’s approach is working as a repeatable business strategy. Attendance alone doesn’t reveal whether an event can generate an adequate return on a six-figure investment, whether sponsors return for a second year or whether the audience grows over time.

There are some encouraging signs on the sponsorship side. With more than 45% of sponsors participating in multiple markets, MedTech World is beginning to build a portfolio that can support expansion rather than requiring each new event to develop its commercial base entirely from scratch.

Malta, meanwhile, remains the benchmark. The flagship has grown to more than 2,000 attendees in recent years and is slated to return in November. The challenge now is turning the three newer events from successful launches into recurring businesses with the same kind of staying power.

An Ecosystem Beyond Events

MedTech World is also careful not to describe itself simply as an event company. Its broader ambition is to build a medical-technology ecosystem that keeps its regional communities engaged between conferences.

To date, it has released three editions of a magazine that lives online and is circulated in print at its events, covering industry trends, founder journeys, emerging technologies and regional healthcare developments. It also launched a podcast in 2023, which is currently in its third season.

Some of those media assets are monetized as additions to sponsorship packages, but Layton said they don’t currently generate meaningful standalone revenue. The company eventually plans to change that.

In the meantime, MedTech World is developing region-specific social content, including content produced in local languages, as another way to maintain those communities throughout the year.

The post appeared first on A Media Operator.